Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
Go back to Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence| AbbVie (NYSE: ABBV) | Delayed: 261.47 +4.35 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $257.12 | 52 Week High | $68.12 | |||
| Open | $261.67 | 52 Week Low | $50.71 | |||
| Day High | $264.65 | P/E | 56.72 | |||
| Day Low | $260.10 | EPS | $4.61 | |||
| Volume | 1,935,826 | |||||
